The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Roche
 
Consulting or Advisory Role - Aduro Biotech; Halozyme
Research Funding - Halozyme (Inst)
Randomized phase II study of PEGPH20 plus nab-paclitaxel/gemcitabine (PAG) vs AG in patients (Pts) with untreated, metastatic pancreatic ductal adenocarcinoma (mPDA).
 
Sunil R. Hingorani
No Relationships to Disclose
 
Andrea J. Bullock
Stock and Other Ownership Interests - Amgen; Johnson & Johnson; Medtronic
Consulting or Advisory Role - Celgene; EMD Serono; Halozyme
 
Tara Elisabeth Seery
Consulting or Advisory Role - Bayer
Speakers' Bureau - Bayer; Ipsen
 
Lei Zheng
Stock and Other Ownership Interests - Z and L International Medical
Consulting or Advisory Role - Merrimack
Research Funding - Amgen; Bristol-Myers Squibb; Gradalis; Halozyme; ITeos Therapeutics; Merck
Patents, Royalties, Other Intellectual Property - GVAX, licensed to Aduro Biotech.
 
Darren Sigal
Stock and Other Ownership Interests - BMS Brazil; Halozyme; Ignyta; Novartis
Honoraria - EMD Serono; Halozyme
Speakers' Bureau - Bayer; Celgene; Novartis
Research Funding - Halozyme (Inst)
 
Paul S. Ritch
No Relationships to Disclose
 
Fadi S. Braiteh
Stock and Other Ownership Interests - Agios; Bristol-Myers Squibb; Clovis Oncology; Insys Therapeutics; Tesaro
Honoraria - Abbott Nutrition; Amgen; ARIAD; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; HERON; Incyte; Insys Therapeutics; Insys Therapeutics; Ipsen; Lexicon; Lilly; Taiho Pharmaceutical
Consulting or Advisory Role - Ambry Genetics; Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Clovis Oncology; Genentech/Roche; Incyte; Insys Therapeutics; Ipsen; Ipsen; Lexicon; Lilly; Merck; Merrimack; Pfizer; Regeneron; Sanofi
Speakers' Bureau - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Incyte; Insys Therapeutics; Ipsen; Lilly; Merck; Merck; Merrimack; Pfizer; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Amgen; AstraZeneca/MedImmune; Bayer; Bayer/Onyx; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Clovis Oncology; Exelixis; HERON; Incyte; Insys Therapeutics; Ipsen; Lexicon; Merrimack; Novartis; Pfizer; Regeneron; Roche/Genentech; Sanofi; Taiho Pharmaceutical; Tesaro
 
Mark Zalupski
Research Funding - Halozyme; Newlink Genetics/Pharmatech; Oncomed
 
Nathan Bahary
Consulting or Advisory Role - Bayer/Onyx; EMD Serono
Research Funding - Newlink Genetics
 
William Proctor Harris
Consulting or Advisory Role - Neo Therma
Research Funding - ArQule (Inst); Exelixis (Inst); Halozyme (Inst); Nordion (Inst); Polaris (Inst)
Travel, Accommodations, Expenses - Halozyme
 
Jie Pu
Employment - Roche
Research Funding - Roche
Patents, Royalties, Other Intellectual Property - Roche; Roche (Inst)
 
Carrie Aldrich
No Relationships to Disclose
 
Sihem Khelifa
Employment - Ventana Medical Systems
Stock and Other Ownership Interests - Ventana Medical Systems
Patents, Royalties, Other Intellectual Property - Pending Patent (Inst)
 
Xionghua W. Wu
Employment - Halozyme
Stock and Other Ownership Interests - Halozyme
 
Joaquina Baranda
Employment - Halozyme
Research Funding - Novartis
 
Ping Jiang
Employment - Halozyme
Stock and Other Ownership Interests - Halozyme
Patents, Royalties, Other Intellectual Property - Halozyme
 
Andrew Eugene Hendifar
Consulting or Advisory Role - Genentech; Ipsen; Novartis; Perthera
Travel, Accommodations, Expenses - Halozyme